Sites of metastasis (mets) and association with clinical outcomes (CO) in metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (cabo).

被引：0
|
作者：
Martini, Dylan J.
Shabto, Julie M.
Liu, Yuan
Carthon, Bradley Curtis
Speak, Alexandra
Hitron, Elise
Russler, Greta
Caulfield, Sarah
Ogan, Kenneth
Harris, Wayne
Master, Viraj A.
Kucuk, Omer
Bilen, Mehmet Asim
机构：
[1] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA
[2] Emory Univ, Dept Biostat, Atlanta, GA 30322 USA
[3] Emory Univ, Dept Bioinformat, Atlanta, GA 30322 USA
[4] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[5] Emory Univ, Sch Med, Dept Pharmaceut Serv, Atlanta, GA USA
[6] Emory Univ, Sch Med, Dept Urol, Atlanta, GA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.585
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
585
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Effect of CBM588 in combination with cabozantinib plus nivolumab for patients (pts) with metastatic renal cell carcinoma (mRCC): A randomized clinical trial.
    Ebrahimi, Hedyeh
    Meza, Luis A.
    Lee, Keehoon
    Malhotra, Jasnoor
    Alcantara, Marice
    Zengin, Zeynep Busra
    Dizman, Nazli
    Govindarajan, Ameish
    Hsu, Joann
    Llamas-Quitiquit, Marian
    Chawla, Neal Shiv
    Castro, Daniela V.
    Mercier, Benjamin D.
    Liu, Sandy
    Chehrazi-Raffle, Alex
    Dorff, Tanya B.
    Frankel, Paul Henry
    Li, Xiaochen
    Pal, Sumanta Kumar
    Tripathi, Abhishek
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (17)
  • [32] Immunomodulatory activity of nivolumab in metastatic renal cell carcinoma (mRCC): Association of biomarkers with clinical outcomes
    Choueiri, Toni K.
    Fishman, Mayer N.
    Escudier, Bernard
    McDermott, David F.
    Kluger, Harriet M.
    Stadler, Walter Michael
    Perez-Gracia, Jose Luis
    McNeel, Douglas G.
    Curti, Brendan D.
    Harrison, Michael Roger
    Plimack, Elizabeth R.
    Appleman, Leonard Joseph
    Fong, Lawrence
    Drake, Charles G.
    Young, Tina C.
    Chasalow, Scott D.
    Ross-Macdonald, Petra
    Simon, Jason S.
    Walker, Dana
    Sznol, Mario
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] IMMUNOMODULATORY ACTIVITY OF NIVOLUMAB IN METASTATIC RENAL CELL CARCINOMA (MRCC): ASSOCIATION OF BIOMARKERS WITH CLINICAL OUTCOMES
    Choueri, Toni K.
    Fishman, Mayer N.
    Escudier, Bernard
    McDermott, David F.
    Kluger, Harriet
    Stadler, Walter M.
    Perez-Gracia, Jose L.
    McNeel, Douglas
    Curti, Brendan
    Harrison, Michael R.
    Plimack, Elizabeth R.
    Appleman, Leonard
    Fong, Lawrence
    Drake, Charles G.
    Young, Tina C.
    Chasalow, Scott D.
    Ross-Macdonald, Petra
    Simon, Jason S.
    Walker, Dana
    Sznol, Mario
    Asia-Pacific Journal of Clinical Oncology, 2015, 11 : 119 - 119
  • [34] SUNITINIB IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS (PTS) WITH BRAIN METASTASES (METS): DATA FROM AN EXPANDED-ACCESS STUDY
    Bracarda, S.
    Hariharan, S.
    Szczylik, C.
    Porta, C.
    Hawkins, R.
    Bjarnason, G. A.
    Oudard, S.
    Lee, S. H.
    Carteni, G.
    Gore, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 182 - 182
  • [35] Immune cell changes in the peripheral blood of metastatic renal cell carcinoma (mRCC) patients (pts) treated with sunitinib or temsirolimus
    Salas, R. N.
    Ireland, J. L.
    Ko, J. S.
    Elson, P.
    Garcia, J. A.
    Wood, L.
    Bukowski, R. M.
    Rini, B. I.
    Finke, J. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] Metastatic renal cell carcinoma (mRCC) patients (pts) with sarcomatoid features treated with VEGF-targeted therapy
    Golshayan, A. R.
    George, S.
    Heng, D. Y.
    Elson, P.
    Wood, L.
    Garcia, J. A.
    Aydin, H.
    Zhou, M.
    Bukowski, R. M.
    Rini, B. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] Impact of metformin on outcomes in patients (pts) with metastatic renal cell carcinoma (mRCC): Results from a pooled clinical trials database.
    Hamieh, Lana
    Mckay, Rana R.
    Mickey, Suzanne S.
    Lin, Xun
    Simantov, Ronit
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [38] Efficacy and safety of everolimus in elderly patients (pts) with metastatic renal cell carcinoma (mRCC)
    Osanto, S.
    Hutson, T. E.
    Calvo, E.
    Escudier, B. J.
    Oudard, S.
    Porta, C.
    Bracarda, S.
    Grunwald, V.
    Ravaud, A.
    Motzer, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [39] Retrospective analysis of risk factors for fatigue in clinical trial patients (pts) with metastatic renal cell carcinoma (mRCC).
    Gore, Martin Eric
    Gruenwald, Viktor
    Motzer, Robert John
    Quinn, David I.
    Rini, Brian I.
    Lin, Xun
    Perkins, Julia Jane
    Simantov, Ronit
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [40] Outcomes of patients (pts) with metastatic renal cell carcinoma (mRCC) treated with pazopanib after progression on other targeted therapies (TT): Updated results
    Matrana, Marc Ryan
    Duran, Cihan
    Shetty, Aditya
    Xiao, Lianchun
    Atkinson, Bradley J.
    Corn, Paul G.
    Charnsangavej, Chusilp
    Jonasch, Eric
    Tannir, Nizar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
12345